Quick Answer
Pharming Group N.V. reported Gross Profit of $261.80 million for fiscal year 2024.
Pharming Group N.V. Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2024 | $261.80M | +18.9% |
| 2023 | $220.10M | +17.0% |
| 2022 | $188.06M | +5.8% |
| 2021 | $177.73M | -5.8% |
| 2020 | $188.63M | +27.7% |
| 2019 | $147.67M | +30.7% |
| 2018 | $112.95M | — |
- Pharming Group N.V. showed an increase of +18.9% in Gross Profit compared to the prior fiscal year.
- Over the 2018–2024 period, Pharming Group N.V.’s gross profit has grown by 131.8% (from $112.95 million to $261.80 million).
- The most recent figure is from Pharming Group N.V.’s fiscal year 2024 report (Form 20-F), filed with the SEC on April 3, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: